Nonpegylated liposomal doxorubicin (TLC-D99), paclitaxel, and trastuzumab in HER-2-overexpressing breast cancer: a multicenter phase I/II study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples